Tevogen Bio Leverages Microsoft Partnership to Deliver Machine Learning Based Target Identification to Address Human Papilloma Virus (HPV), Advancing TVGN 920 Tevogen Bio begins pre-clinical effort for TVGN 920, signaling the start of its oncology treatment pipeline.Tevogen Bio created a data set containing known proteins in the HPV genome to identify...

Tevogen Bio Takes Lead in Developing Cell Therapies Designed to Eradicate Post Procedure Human Papilloma Virus in Women with Precancerous Cervical Lesions Approximately one in three women remain HPV positive after cervical procedures for precancerous lesions.Tens of thousands of women in the US each year are diagnosed with high-grade cervical...

Microbix QAPs Supporting HPV Testing Across The Netherlands MISSISSAUGA, Ontario, July 05, 2023 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces that its...

Vaccines Market Worth $187 Billion in 2021- Exclusive Report by Meticulous Research® Redding, California, Oct. 26, 2021 (GLOBE NEWSWIRE) -- According to a new market research report titled “Vaccines Market by Indication (Pneumococcal, Influenza, Rotavirus, Hepatitis, COVID-19),...

Vaccines Market worth over $70bn by 2025: Global Market Insights, Inc. Selbyville, Delaware, March 07, 2019 (GLOBE NEWSWIRE) -- The vaccines market is estimated to hike from over USD 38 billion in 2018 to over USD 70 billion by 2025, according to a 2019 Global Market...